A molecular diagnostics company focused on genetic analysis technologies, particularly noninvasive prenatal testing based on cell‑free fetal DNA. Its flagship MaterniT21 test helped pioneer commercial screening for chromosomal abnormalities using a maternal blood sample, positioning the firm within ...
2 members of Congress have disclosed 10 trades in 216994 (SQNM), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 4 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-12-31 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-08-23 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2011-12-01 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2011-08-10 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2011-07-10 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2011-07-09 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2011-07-09 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2010-08-03 | SHELLEY BERKLEY | buy | -705.53 |
| 2010-05-02 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2008-03-10 | MICHAEL T. MCCAUL | buy | $1K – $15K |